The Survey is promoted by the OneHealthdrugs COST Action and falls within the goals of WG6 that oversees the development of this action. The objective is to assemble and then disseminate information on PVBD in a One Health context, promote discussion on topics relevant to OneHealthDrugs CA 21111, and translate the outcomes of these activities into outputs that benefit the Action’s membership and the larger PVBD community from Medicinal Chemistry researchers to veterinarians and ecologists. The environmental impact of medications on the veterinary/human interface is a core interest of the Action and the proposed survey contributes to our understanding of the extent of the problem, its challenges and opportunities for the implementation of potential remedies. 

Objectives and direct outcome of this data collection

From this survey, we should provide OneHealthDrugs CA 21111 and the broader community with the following information: 

1. A first cataloguing of the anti-PVBDs drugs being most often applied to animals in European and neighbour countries, indirectly contaminating the environment. 

This approach will provide a landscape view of regional and European needs and applications of drugs against PVBDs cross-referenced to target animal species, disease and usage scale. This will identify the most diagnosed PVBD of animals in each country and their respective chemoprophylactic and therapeutic approaches. This information, so far unavailable, is the necessary foundation to support future assessment of environmental distribution and impact of such drugs, mapped by country or region. This provides invaluable support for decision making, e.g. the identification of the drugs in most urgent need of replacement, setting up priorities for research on new drug development.

1. Characterization of Veterinarians’ practice that contribute to the environmental impact of pharmacological treatments and their endlines. 

From the analysis of veterinarian’s practicalities towards environmental impact of anti-PVBD drugs, a follow-on strategy of targeted information can be designed to support veterinarians prioritizing actions to reduce the environmental burden of veterinary drugs.

1. Summary and analysis of the survey to promote awareness of PVBDs in Europe in knowledge and practices towards a rational and One Health approach of drugs use. 

The main aim is to inform stakeholders in the field and the European commission to provide guidelines and recommendation in the field.

To favour this action, dissemination activities will be undertaken and publication/s. From the questionnaire, we intend to publish a paper in an Open Access academic journal providing a summary and analysis of the survey. Based on the analysis, OneHealthDrugscan initiate and lead a discussion on the topic and offer recommendations for the future of anti-parasitic drugs, considering One Health priorities of intervention from the research bench to field applications.